Tempus AI, Inc.

Tempus, Inc. creates Intelligent Diagnostics by applying artificial intelligence (AI) in healthcare. These diagnostics use AI, including generative and agentic AI, to make laboratory tests more accurate, tailored, and personal. The company personalizes test results by connecting laboratory results to a patient's clinical data. Tempus's approach recognizes that all laboratory test results, genomic or otherwise, can be contextualized for a specific patient based on their unique characteristics, guiding therapy selection and treatment decisions. This allows for the refinement of drug recommendations, clinical trial exploration, care pathway evaluations, and adverse event considerations when test results are linked to a patient's personal profile. To achieve this, Tempus built the Tempus Platform, which includes a technology platform to free healthcare data from silos and an operating system to make the data useful. Through its proprietary technology, Tempus has amassed a large library of clinical and molecular oncology data. The company aims to embed AI, including generative AI, throughout diagnostics to enable physicians and researchers to make personalized, data-driven decisions that improve patient care. The deployment of AI in precision medicine at scale has become possible due to advances in cloud computing, imaging technologies, large language models, low-cost molecular profiling, and the digitization of healthcare data. Despite increased data availability, much healthcare data remains disconnected, lacking harmonization and structure, which limits its use by physicians and researchers.